NT5E and cancer: Wu et al.[36] and Mikhailov et al.[37] observed that AOPCP, a CD73 enzyme activity inhibitor, could not completely block the effect of CD73 in cell proliferation and TRAIL‐induced apoptosis of cancer cells, respectively, implying an enzyme independent activity of CD73.